Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Short term Debt (2019 - 2025)

Hypha Labs filings provide 11 years of Short term Debt readings, the most recent being $226078.0 for Q3 2025.

  • On a quarterly basis, Short term Debt fell 79.03% to $226078.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $226078.0, a 79.03% decrease, with the full-year FY2025 number at $226078.0, down 79.03% from a year prior.
  • Short term Debt hit $226078.0 in Q3 2025 for Hypha Labs, down from $1.2 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.7 million in Q2 2022 to a low of $90112.0 in Q1 2021.
  • Median Short term Debt over the past 5 years was $1.1 million (2024), compared with a mean of $923904.7.
  • Biggest five-year swings in Short term Debt: skyrocketed 2442.44% in 2021 and later plummeted 88.23% in 2022.
  • Hypha Labs' Short term Debt stood at $1.3 million in 2021, then plummeted by 88.23% to $150000.0 in 2022, then surged by 838.63% to $1.4 million in 2023, then decreased by 23.42% to $1.1 million in 2024, then tumbled by 79.03% to $226078.0 in 2025.
  • The last three reported values for Short term Debt were $226078.0 (Q3 2025), $1.2 million (Q2 2025), and $1.1 million (Q1 2025) per Business Quant data.